For the Inventor, By the Inventor

Enter assignee name

Denver, CO, United States of America

National Jewish Health

USPTO Granted Patents = 88

CIPO Patents = 4

EPO Patents = 15

Trademarks = 24

Forward Citations = 221

Loading Chart...

Loading Chart...

85 inventors (with patents filed for the assignee):

Erwin W Gelfand (10 out of 23 patents)

Brian J Day (9 out of 24 patents)

Carl W White (7 out of 9 patents)

4. Jerry A Nick (7 out of 7 patents)

5. Milene Saavedra (7 out of 7 patents)

6. Yosef Refaeli (5 out of 33 patents)

7. Brian Curtis Turner (5 out of 29 patents)

8. James D Crapo (5 out of 26 patents)

9. Donald Y M Leung (5 out of 7 patents)

10. Elena Goleva (5 out of 5 patents)

11. John C Cambier (5 out of 8 patents)

12. Max Seibold (5 out of 5 patents)

13. Stephen M Humphries (5 out of 5 patents)

14. Dennis R Voelker (5 out of 5 patents)

15. William P Schiemann (5 out of 6 patents)

Core Competencies:

Pulmonary Disorders

Cystic Fibrosis

Airway Inflammatory Diseases

RNA-Guided Genome Editing

Atopic Dermatitis

Selenocyanate Treatment

Dynamic Feature Classification

Respiratory Diseases

Stem Cells

Allergic Conditions

Cancer Cell Colonization

Lipid Abnormalities

88 patents: Sort by Forward Citations

1. 12482124 - Systems and methods of volumetrically assessing structures of skeletal cavities (2025-11-25),

2. 12410477 - Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders (2025-09-09),

3. 12153055 - Methods of detecting and treating airway inflammatory diseases (2024-11-26),

4. 12146875 - Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation (2024-11-19),

5. 12117446 - Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases (2024-10-15),

6. 12084695 - Treatment for airway cast obstruction (2024-09-10),

7. 12043601 - N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same (2024-07-23),

8. 11986450 - Methods and compositions for treating infection and inflammation with selenocyanate (2024-05-21),

9. 11963965 - Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction (2024-04-23),

10. 11937937 - Methods of identifying atopic dermatitis and food allergies (2024-03-26),

11. 11932867 - Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene (2024-03-19),

12. 11922626 - Systems and methods for automatic detection and quantification of pathology using dynamic feature classification (2024-03-05),

13. 11709169 - Lipid abnormalities and association with atopic allergic diseases (2023-07-25),

14. 11649503 - Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders (2023-05-16),

15. 11494902 - Systems and methods for automatic detection and quantification of pathology using dynamic feature classification (2022-11-08),

National Jewish Health is a leading respiratory hospital located in Denver, Colorado. With over 120 years of experience, the hospital specializes in the treatment and research of respiratory, allergic, and immune- related diseases. National Jewish Health is dedicated to providing the highest quality care for patients while advancing the understanding and treatment of respiratory diseases through research and education.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

88 Patents

#12 in Denver, CO

#79 in Colorado

#4,095 in US

#8,451 in the World

Denver, CO, United States of America

National Jewish Health

Forward Citations = 221

85 inventors:

Erwin W Gelfand (10 out of 23 patents)

Brian J Day (9 out of 24 patents)

Carl W White (7 out of 9 patents)

4. Jerry A Nick (7 out of 7 patents)

5. Milene Saavedra (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…